Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05840952
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-31
First Post:
2023-04-10
Brief Title:
A Study in Healthy Volunteers to Evaluate the Safety Tolerability Pharmacokinetics and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
Sponsor:
Aligos Therapeutics
Organization:
Aligos Therapeutics
Study Overview
Official Title:
A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety Tolerability Pharmacokinetics and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multi-part study of ALG-097558 to evaluate safety tolerability pharmacokinetics and drug-drug interaction potential after single and multiple doses in healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None